Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Filip, Gorachinov"'
Autor:
Filip Gorachinov, Fatima Mraiche, Diala Alhaj Moustafa, Ola Hishari, Yomna Ismail, Jensa Joseph, Maja Simonoska Crcarevska, Marija Glavas Dodov, Nikola Geskovski, Katerina Goracinova
Publikováno v:
Beilstein Journal of Nanotechnology, Vol 14, Iss 1, Pp 240-261 (2023)
Genomic and proteomic mutation analysis is the standard of care for selecting candidates for therapies with tyrosine kinase inhibitors against the human epidermal growth factor receptor (EGFR TKI therapies) and further monitoring cancer treatment eff
Externí odkaz:
https://doaj.org/article/4720eb222e7549458be181158a791d7b
Autor:
Nikola Geskovski, Fatima Mraiche, Huseyin C. Yalcin, Filip Gorachinov, Diala A. Moustafa, Simona Dimchevska, Marija Glavas Dodov, Maja Simonoska Crcarevska, Katerina Goracinova
Publikováno v:
Macedonian Pharmaceutical Bulletin. 68:21-22
The success of design criteria for long-circulating drug delivery systems to support membrane receptor-ligand interaction and internalization has been limited and there is a need to develop smarter approaches for efficient drug tumor targeting. In or
Autor:
Sarra Aicha, Koummich, Ikram Mustapha, Zoukh, Filip, Gorachinov, Nikola, Geskovski, Petre, Makreski, Marija Glavas, Dodov, Katerina, Goracinova
Publikováno v:
Drug delivery and translational research. 12(6)
Diclofenac sodium 0.1% is a commonly used NSAID with well-documented clinical efficacy in reducing postoperative inflammation; however, its corneal tolerability and ophthalmic tissue bioavailability require further improvement. Advanced micellar deli